Angiotensin Converting Enzyme Inhibitors Market: Business overview, Upcoming Trends and Top Company Analysis Forecast – 2027

The Global Angiotensin Converting Enzyme Inhibitors Market was valued at US$ 11,693.6 million in 2017, and is expected to witness a CAGR of 3% during the forecast period 2021 – 2027.

Angiotensin-converting enzyme inhibitors are a group of drugs used to treat heart failure, high blood pressure (high blood pressure), or reduce complications of myocardial infarction (heart attack). These drugs are also useful to slow the progression of kidney disease in people with chronic kidney disease or to slow kidney disease in people with diabetes. The mechanism of action of geotensin converting enzyme inhibitors is to decrease the amount of geotensin II produced. Angiotensin II acts on the body to increase pressure in the kidneys, blood volume and blood pressure.

(Get 15% Discount on Buying this Report)

A full report of Global Angiotensin Converting Enzyme Inhibitors Market is available at: https://www.orionmarketreports.com/request-sample/?id=69125  

Market Segments

On the basis of product

● Benazepril (Lotensin)

● Captopril
● Enalapril (Vasotec)
● Fosinopril
● Lisinopril (Prinivil, Zestril)
● Moexipril
● Perindopril
● Quinapril (Accupril)
● Ramipril (Altace)
● Trandolapril

On the basis of the end users/applications

● Coronary Artery Disease

● Heart Failure
● Diabetes
● Chronic Kidney Diseases
● Heart Attacks
● Scleroderma
● Migraines
● Others

Key Players

Key players operating in the angiotensin converting enzymes (ACE) inhibitors market include, Pfizer, Inc., AstraZeneca Pharmaceutical Company, Novartis AG, Daiichi Sankyo Company, Ltd., United Therapeutics Corporation, Sanofi S.A., Johnson & Johnson Services, Inc., Merck KGaA, Takeda Pharmaceutical Company, and  Bayer AG.

Scope of the Report

The research study analyzes the global Angiotensin Converting Enzyme Inhibitors industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

A full report of Global Angiotensin Converting Enzyme Inhibitors Market is available at: https://www.orionmarketreports.com/angiotensin-converting-enzyme-inhibitors-market/69125/  

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Angiotensin Converting Enzyme Inhibitors Market Report

1. What was the Angiotensin Converting Enzyme Inhibitors Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027).

2. What will be the CAGR of the Angiotensin Converting Enzyme Inhibitors Market during the forecast period (2021-2027)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
4. Which manufacturer/vendor/players in the Angiotensin Converting Enzyme Inhibitors Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.

The report covers the following objectives:

  • Proliferation and maturation of trade in the global Angiotensin Converting Enzyme Inhibitors market.
  • The market share of the global Angiotensin Converting Enzyme Inhibitors market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
  • Current and future market trends that are influencing the growth opportunities and growth rate of the global Angiotensin Converting Enzyme Inhibitors market.
  • Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Angiotensin Converting Enzyme Inhibitors market.

For more customized data, request for report customization @ https://www.orionmarketreports.com/inquiry-before-buying/?id=69125

About Us:

Orion Market Reports (OMR) endeavors to provide an exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and the most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.

Media Contact:

Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404

Leave a Reply

Your email address will not be published. Required fields are marked *